Zobrazeno 1 - 10
of 22
pro vyhledávání: '"F. Lebras"'
Autor:
A. Mokhri, Silvia Oghina, J. Dupuis, K. Beladj, S. Guendouz, V. Frenkel, P. Issaurat, T. Damy, Mélanie Bézard, F. Lebras, Arnault Galat, J.L. Dubois-Randé, F. Gilles, Mounira Kharoubi, Diane Bodez
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:44-45
Background Light-chain amyloidosis (AL) with cardiac involvement carries a poor prognosis; median untreated survival is Purpose Our study evaluates the effect on mortality of first-line chemotherapy administered in combined or in sequential in patien
Autor:
Thibaud Damy, Arnault Galat, Violaine Planté-Bordeneuve, Mounira Kharoubi, S. Rouffiac, F. Lebras, N. De Nadai, A. Amiot, K. Ayad, Jean-Luc Dubois-Randé, Diane Bodez, Soulef Guendouz, Costin Radu
Publikováno v:
European Heart Journal. 38
Autor:
F. Lebras, Dania Mohty, J.L. Dubois-Randé, David Attias, S. Guendouz, Wulfran Bougouin, Violaine Planté-Bordeneuve, Diane Bodez, Eric Bergoend, E. Itti, Luc Hittinger, Mounira Kharoubi, Arnault Galat, T. Damy, Jean Francois Deux
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:e288
Introduction Cardiac amyloidosis (CA) is a severe disease, often lethal. Little is known about cause of death during the natural course of CA. Identification of cause of death during CA is of particular interest to design clinical trials and identify
Autor:
J.L. Dubois Randé, Mounira Kharoubi, T. Damy, B. Funalot, D. Azoulay, Arnault Galat, S. Guendouz, Diane Bodez, V. Audart, J.-P. Couetil, F. Lebras, K. Belhadj, L. Salomon, C. Duvoux, N. Mongardon, Violaine Planté-Bordeneuve
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:42
Introduction Cardiac Amyloidosis (CA) is caused by the extracellular accumulation of insoluble fibrillar proteins. The most common types of CA are AL amyloidosis (light-chain), transthyretin amyloidosis: Hereditary (hTTR) or wild-type (wTTR). Without
Autor:
M. Gomes da Silva, Herve Ghesquieres, F. Broussais, O. Tournilhac, E. Nicolas-Virelizier, Guillaume Cartron, Ghandi Damaj, C. Lancesseur, Remy Gressin, Christophe Bonnet, Luc Mathieu Fornecker, Sarah Bailly, Gilles Salles, E. Tchernonog, R. Delarue, Gaelle Fossard, F. Lebras, E. Toussaint, E. Gyan, R. Bouabdallah, Evelyne Willems, Emmanuel Bachy, Ines Coelho, Adrien Chauchet, Corinne Haioun, P. Gaulard
Publikováno v:
Hematological Oncology. 35:76-77
Autor:
Gaëlle Godeneche, L. Boissonnot, N. Moinot, Jonathan Ciron, M.-S. Artaud-Uriot, Jean-Philippe Neau, F. Lebras, Stéphane Mathis, Delphine Larrieu, P. Ingrand, J.-Y. Bounaud, V. Lhomme
Publikováno v:
Revue Neurologique. 167:317-323
Resume Introduction Des travaux recents montrent l’implication de la vitamine D dans la sclerose en plaques (SEP). Methodes Dans un travail pluricentrique regional (region Poitou-Charentes) realise pendant le premier trimestre 2010, nous avons dose
Autor:
J P, Neau, M S, Artaud-Uriot, V, Lhomme, J Y, Bounaud, F, Lebras, L, Boissonnot, N, Moinot, J, Ciron, D, Larrieu, S, Mathis, G, Godeneche, P, Ingrand
Publikováno v:
Revue neurologique. 167(4)
Recent reports demonstrate the implication of vitamin D in multiple sclerosis (MS).In a multicentric regional study (Poitou-Charentes area) during the first trimester 2010, we measured the 25-OH vitamin D serum level in 170 consecutive MS patients, a
Autor:
N, Moinot, O, Anne, J-L, Devoize, M S, Artaut-Uriot, I, Aubert-Cetou, L, Boissonnot, C, Debras, F, Lebras, P-Y, Loll, G, Godeneche, V, Mesnage, J-P, Neau
Publikováno v:
Revue neurologique. 163(12)
One hundred and sixty four patients of the Poitou-Charentes area suffering from multiple sclerosis (MS) and treated with an immunomodulating agent for more than 3 months completed a self-administered questionnaire. More than 60p.cent of the patients
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 47:S9